A retrospective audit of the real-world safety and effectiveness profile of eptinezumab for treatment-resistant chronic migraine in Australia
Authors:
Posted in Papers / Human Studies|Original Research / December 1-15, 2025
Headache. 2025 Dec 2. doi: 10.1111/head.70015. Online ahead of print.
PMID: 41331996 | DOI: 10.1111/head.70015
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.